Turbogen director reports 81,676-share stake
Turbogen Ltd. (TRBG) director Gafni Ziv filed an initial ownership report detailing current equity interests.
Rhea-AI Filing Summary
Turbogen Ltd. (TRBG) director Gafni Ziv filed an initial ownership report detailing current equity interests. Ziv holds 81,676 Ordinary shares directly. In addition, Ziv holds options over 30,177 Ordinary shares with an exercise price of $2.99 per share, expiring on March 9, 2032. As of August 25, 2026, 20,118 of these options are fully vested and none have been exercised.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Gafni Ziv
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share option (right to buy) F2, F1 | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Holdings After Transaction:
Share option (right to buy) — 30,177 contracts (Direct);
Ordinary shares — 81,676 shares (Direct)
Footnotes (2)
- F1. A total of 30,177 options were granted on March 9, 2025 and vest in three equal installments of 33.3% beginning March 9, 2025. As of August 25, 2026, 20,118 options are fully vested and none have been exercised into ordinary shares.
- F2. The options were granted with an exercise price of NIS 8.95 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $2.99 per share.
Key Figures
Directly owned Ordinary shares: 81,676 shares
Options underlying Ordinary shares: 30,177 shares
Option exercise price: $2.99 per share
+4 more
7 metrics
Directly owned Ordinary shares
81,676 shares
Direct ownership position reported as of the Form 3 filing date
Options underlying Ordinary shares
30,177 shares
Number of Ordinary shares underlying reported share options
Option exercise price
$2.99 per share
Exercise price converted from NIS 8.95 using NIS 2.994 to USD $1.00 as of August 24, 2026
Vested options
20,118 options
Options fully vested as of August 25, 2026; none exercised
Total options granted
30,177 options
Options granted on March 9, 2025 vesting in three equal installments of 33.3%
Option expiration date
March 9, 2032
Expiration date of the reported share options
FX rate used for exercise price conversion
NIS 2.994 to USD $1.00
Exchange rate as of August 24, 2026 used to convert NIS 8.95 exercise price
Key Terms
Form 3, exercise price, vest in three equal installments, Ordinary shares, +1 more
5 terms
Form 3 regulatory
"For purposes of this Form 3, the exercise price has been converted"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
exercise price financial
"The options were granted with an exercise price of NIS 8.95 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in three equal installments financial
"30,177 options were granted on March 9, 2025 and vest in three equal installments"
exchange rate financial
"using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026"
Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.
FAQ
What does Turbogen Ltd. (TRBG) director Gafni Ziv report on this Form 3?
Gafni Ziv reports direct ownership of 81,676 Ordinary shares of Turbogen Ltd. and options over 30,177 Ordinary shares that are currently unexercised. This filing establishes Ziv’s initial beneficial ownership position as a director of TRBG.
How many options does Gafni Ziv hold in Turbogen Ltd. (TRBG) and at what exercise price?
Gafni Ziv holds 30,177 options to acquire Turbogen Ltd. Ordinary shares at an exercise price of $2.99 per share, converted from NIS 8.95 using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026.
What is the vesting status of Gafni Ziv’s options in Turbogen Ltd. (TRBG)?
The 30,177 options granted on March 9, 2025 vest in three equal installments of approximately 33.3%. As of August 25, 2026, 20,118 options are fully vested and none have been exercised into Ordinary shares.
When do Gafni Ziv’s options in Turbogen Ltd. (TRBG) expire?
The reported share options held by Gafni Ziv to acquire Turbogen Ltd. Ordinary shares have an expiration date of March 9, 2032, providing a long-dated right to purchase up to 30,177 shares at the fixed exercise price of $2.99 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
